Correlation of ENT Symptoms with Age, Sex, and Anti-SARS-CoV-2 Antibody Titer in Plasma
暂无分享,去创建一个
A. Skorek | P. Burduk | D. Tretiakow | Anna Jaźwińska-Curyłło | K. Kwaśniewski | Aleksandra Kwaśniewska
[1] P. Bochud,et al. Anti-SARS-CoV-2 Titers Predict the Severity of COVID-19 , 2022, Viruses.
[2] G. Lisowska,et al. Frequency and Severity of Ear–Nose–Throat (ENT) Symptoms during COVID-19 Infection , 2022, Medicina.
[3] R. Paton,et al. Prevalence and duration of anti-SARS-CoV-2 antibodies in healthcare workers. , 2022, Danish medical journal.
[4] K. Simon,et al. Management of SARS-CoV-2 infection: recommendations of the Polish Association of Epidemiologists and Infectiologists as of February 23, 2022. , 2022, Polish archives of internal medicine.
[5] H. Kunishima,et al. Relationship between changes in symptoms and antibody titers after a single vaccination in patients with Long COVID , 2022, Journal of medical virology.
[6] W. Narożny,et al. Assessment of anti‐SARS‐CoV‐2 antibodies level in convalescents plasma , 2021, Journal of medical virology.
[7] A. Gözalan,et al. Evaluation of antibody response after COVID‐19 vaccination of healthcare workers , 2021, Journal of medical virology.
[8] Ying Shen,et al. Serum Albumin Levels as a Potential Marker for the Predictive and Prognostic Factor in Sudden Sensorineural Hearing Loss: A Prospective Cohort Study , 2021, Frontiers in Neurology.
[9] W. Mansour,et al. Analysis of Ear, Nose and Throat Manifestations in COVID-19 Patients , 2021, International Archives of Otorhinolaryngology.
[10] K. Simon,et al. Management of SARS-CoV- infection: recommendations of the Polish Association of Epidemiologists and Infectiologists as of April 26, 2021. , 2021, Polish archives of internal medicine.
[11] Qianghu Wang,et al. Dynamic changes in anti-SARS-CoV-2 antibodies during SARS-CoV-2 infection and recovery from COVID-19 , 2020, Nature Communications.
[12] E. Hod,et al. Distinct antibody responses to SARS-CoV-2 in children and adults across the COVID-19 clinical spectrum , 2020, Nature Immunology.
[13] M. Güven,et al. Otolaryngological manifestations of hospitalised patients with confirmed COVID-19 infection , 2020, European Archives of Oto-Rhino-Laryngology.
[14] Sin Young Ham,et al. Dynamics of viral load and anti-SARS-CoV-2 antibodies in patients with positive RT-PCR results after recovery from COVID-19 , 2020, The Korean journal of internal medicine.
[15] E. Elibol. Otolaryngological symptoms in COVID-19 , 2020, European Archives of Oto-Rhino-Laryngology.
[16] S. Farhadian,et al. Sex differences in immune responses that underlie COVID-19 disease outcomes , 2020, Nature.
[17] Harnish Mukesh Naik,et al. Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor population. , 2020, The Journal of clinical investigation.
[18] M. Salesi,et al. Clinical efficacy of convalescent plasma for treatment of COVID-19 infections: Results of a multicenter clinical study , 2020, Transfusion and Apheresis Science.
[19] Liyan Wen,et al. Kinetics of viral load and antibody response in relation to COVID-19 severity. , 2020, The Journal of clinical investigation.
[20] S. Elzayat,et al. ENT manifestation in COVID-19 patients , 2020, Auris Nasus Larynx.
[21] Yan Peng,et al. Effectiveness of convalescent plasma therapy in severe COVID-19 patients , 2020, Proceedings of the National Academy of Sciences.
[22] Hui Poh Goh,et al. Treatment of COVID-19: old tricks for new challenges , 2020, Critical Care.
[23] M. Fernández‐Reyes,et al. Serum potassium concentrations: Importance of normokalaemia. , 2017 .
[24] M. Heras,et al. Serum potassium concentrations: Importance of normokalaemia. , 2017, Medicina clinica.
[25] C. Ki,et al. Possible Transfusion-Related Acute Lung Injury Following Convalescent Plasma Transfusion in a Patient With Middle East Respiratory Syndrome , 2016, Annals of laboratory medicine.
[26] J. Sung,et al. Retrospective comparison of convalescent plasma with continuing high‐dose methylprednisolone treatment in SARS patients , 2004, Clinical Microbiology and Infection.